ArticleCureus2025
Splenic and Pancreatic Abscess Secondary to Chronic Corticosteroid Use: A Case Report and Literature Review.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Splenic abscess is a rare but potentially life-threatening condition often associated with immunosuppressive states. We present the case of a 62-year-old man with a history of chronic corticosteroid use who developed fever, anorexia, weight loss, and left upper quadrant abdominal pain. Laboratory studies revealed leukocytosis and elevated inflammatory markers. Contrast-enhanced computed tomography identified multiloculated abscesses in the spleen and pancreatic tail. The patient underwent exploratory laparotomy, splenectomy, and distal pancreatectomy, with a favorable postoperative course complicated only by a superficial surgical site infection. Splenic abscess typically results from hematogenous spread, and its diagnosis is often delayed due to nonspecific symptoms. Imaging, particularly contrast-enhanced CT, is critical for early detection. Management strategies include percutaneous drainage or surgical intervention, depending on the patient's clinical status. Although corticosteroid-induced immunosuppression is a rare risk factor, it should be recognized as a potential cause. Early diagnosis, source control, and targeted antibiotic therapy are crucial for optimizing patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.